School of Engineering and Department of Orthopaedics & Rehabilitation, University of Vermont, Burlington, Vermont 05405, USA.
J Orthop Res. 2012 Mar;30(3):482-8. doi: 10.1002/jor.21534. Epub 2011 Aug 22.
Injection of soluble cell signaling factors into degenerated intervertebral discs (IVDs) offers a minimally invasive treatment that could limit the processes of degeneration by stimulating native matrix repair. This study evaluated the regenerative capacity of degenerated nucleus pulposus (NP) cells obtained from patients undergoing anterior interbody fusions by measuring metabolic activity, DNA content, glycosaminoglycan (GAG) content, and cellular phenotype using qRT-PCR profiling with a custom array of 42 genes. NP cells were cultured in alginate for 7 days with 4 treatment groups: transforming growth factor beta 3 (TGFβ3) + dexamethasone (Dex), soluble factors released from notochordal cells (NCs) cultured in alginate (NCA), soluble factors released from NCs in their native tissue environment (NCT), and basal media. TGFβ3 + Dex stimulated degenerated human NP cells to proliferate and exhibit an anti-catabolic gene expression profile (with a decrease in ADAMTS5 and MMP1 compared to basal, and an increase in SOX9, decrease in ADAMTS5, MMP1, collagen I and collagen III compared to day 0), while NCA stimulated the greatest GAG per cell. We conclude that degenerated human NP cells exhibit regenerative potential, and that an optimal treatment will likely require treatments, such as TGFβ3 + Dex, which were able to increase cell metabolism and reduce catabolism, as well as treatments with factors found in NC conditioned medium, that were able to produce high amounts of GAG per cell. Additional studies to optimize NC culture conditions are required to determine if NC conditioned medium can be made with the capacity to enhance NP cell proliferation and metabolism.
将可溶性细胞信号因子注入退变的椎间盘中(IVD)提供了一种微创治疗方法,通过刺激天然基质修复来限制退变过程。本研究通过测量代谢活性、DNA 含量、糖胺聚糖(GAG)含量和使用定制的 42 个基因阵列进行 qRT-PCR 分析来评估从接受前路椎间融合术的患者中获得的退变髓核(NP)细胞的再生能力。NP 细胞在藻酸盐中培养 7 天,有 4 个治疗组:转化生长因子β 3(TGFβ3)+地塞米松(Dex)、藻酸盐中培养的脊索细胞(NC)释放的可溶性因子(NCA)、NC 在其天然组织环境中释放的可溶性因子(NCT)和基础培养基。TGFβ3+Dex 刺激退变的人 NP 细胞增殖并表现出抗分解代谢基因表达谱(与基础相比,ADAMTS5 和 MMP1 减少,SOX9 增加,与第 0 天相比,ADAMTS5、MMP1、胶原 I 和胶原 III 减少),而 NCA 刺激每个细胞产生的 GAG 最多。我们得出结论,退变的人 NP 细胞具有再生潜力,而最佳治疗方法可能需要治疗方法,例如 TGFβ3+Dex,它能够增加细胞代谢并减少分解代谢,以及使用 NC 条件培养基中发现的因子的治疗方法,能够产生大量的 GAG 每个细胞。需要进一步的研究来优化 NC 培养条件,以确定 NC 条件培养基是否可以增强 NP 细胞的增殖和代谢能力。